MaaT Pharma Overview
- Founded
- 2014

- Status
- Private
- Employees
- 34

- Latest Deal Type
- Series B
- Latest Deal Amount
- $30M

- Investors
- 9
MaaT Pharma General Information
Description
Developer of microbiome restoration biotherapeutics designed to improve the survival outcome of blood cancer. The company's biotherapeutics focus on onco-hematology and acute myeloid leukemia, enabling doctors to treat life-threatening diseases.
Contact Information
- 317 Avenue Jean Jaurès
- 69007 Lyon
- France
MaaT Pharma Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
5. Later Stage VC (Series B) | 01-Dec-2020 | $30M | 000.00 | 000.00 | Completed | Clinical Trials - Phase 2 |
4. Accelerator/Incubator | 29-Oct-2016 | 00.000 | Completed | Startup | ||
3. Early Stage VC (Series A) | 22-Mar-2016 | 000.00 | 00.000 | 000.00 | Completed | Startup |
2. Early Stage VC | 24-Jul-2015 | $1.11M | $2.33M | Completed | Startup | |
1. Seed Round | 09-Jan-2015 | $1.22M | $1.22M | Completed | Startup |
MaaT Pharma Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
P3 Shares | 000,000 | 00.000000 | 000.00 | 000.00 | 00 | 000.00 | 00.000 | |
P2 | 000,000 | 00.000000 | 000.00 | 000.00 | 00 | 000.00 | 00.00 | |
O | 00,000 | 00.000000 | 000.00 | 000.00 | 000.00 | 0.000 | ||
P | 00,000 | 00.000000 | ||||||
P | 0,000 | 00.000000 | ||||||
P | 00,000 | 00.000000 | ||||||
O | 15,637 | $0.592239 | ||||||
O | 74,300 | $0.592239 |
MaaT Pharma Comparisons
Industry
00000 00
00000 00
PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.
Request a free trialMaaT Pharma Competitors (18)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Axial Therapeutics | Venture Capital-Backed | Waltham, MA | 00 | 000.00 | 00000000000 | 000.00 |
00000 000000000000 | Formerly VC-backed | Cambridge, MA | 000 | 00000 | 00000000 | 00000 |
00000000 | Venture Capital-Backed | Cambridge, MA | 000.00 | 0000000000 0 | 000.00 | |
00000 (0000 000000 | Venture Capital-Backed | Somerville, MA | 000 | 00000 | 00000000000 | 00000 |
000000 000000 | Venture Capital-Backed | Brisbane, CA | 00 | 000.00 | 00000000000 | 000.00 |
MaaT Pharma Executive Team (11)
MaaT Pharma Board Members (10)
Name | Representing | Role | Since |
---|---|---|---|
Claude Bertrand | MaaT Pharma | Board Member | 000 0000 |
Herve Affagard | MaaT Pharma | Co-Founder, Chief Executive Officer & Board Member | 000 0000 |
Isabelle de Cremoux | Seventure Partners | Board Member | 000 0000 |
Jean-Marie Lefevre | MaaT Pharma | Chairman of the Board | 000 0000 |
Julien Samson | Self | Board Member | 000 0000 |
MaaT Pharma Signals
Growth Rate

Growth

Size Multiple


Key Data Points
Twitter Followers
5.5k

Similarweb Unique Visitors
15.0K

Majestic Referring Domains
314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialMaaT Pharma Investors (9)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
Bpifrance | Sovereign Wealth Fund | Minority | 000 0000 | 000000 0 | |
Celeste Management (Switzerland) | Family Office | Minority | 000 0000 | 000000 0 | |
Skyviews Life Science | Corporation | Minority | 000 0000 | 000000 0 | |
SymBiosis | Corporation | Minority | 000 0000 | 000000 0 | |
BigBooster | Accelerator/Incubator | Minority | 000 0000 | 000000 0 |